BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16124380)

  • 1. [Mean arterial blood flow depends on the intensity of thyrotoxicosis in patients with Graves' disease].
    Czarkowski M; Hilgertner L; Powałowski T; Radomski D
    Pol Merkur Lekarski; 2005 Jun; 18(108):667-70. PubMed ID: 16124380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
    Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
    Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the resistance of large conduit arteries also decreased in thyrotoxic patients with Graves' disease?
    Czarkowski M; Hilgertner L; Powałowski T; Radomski D; Mikulska M
    Thyroid; 2005 Apr; 15(4):377-81. PubMed ID: 15876163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stiffness of the common carotid artery in patients with Graves' disease.
    Czarkowski M; Hilgertner L; Powałowski T; Radomski D
    Int Angiol; 2002 Jun; 21(2):152-7. PubMed ID: 12110776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of colour Doppler sonography in patients with Graves' disease.
    Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
    West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
    Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
    J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis.
    Hari Kumar KV; Pasupuleti V; Jayaraman M; Abhyuday V; Rayudu B R; Modi KD
    Endocr Pract; 2009; 15(1):6-9. PubMed ID: 19211390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of color doppler ultrasonography, thyroid function and auto antibody for the screening of Graves' disease in pregnancy].
    Xue M; Shi QL; Tan KN; Wu Y; Zhou R
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):470-3. PubMed ID: 27256611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of thyrotoxicosis during pregnancy with color flow Doppler sonography.
    Hari Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Meena U; Modi KD
    Int J Gynaecol Obstet; 2008 Aug; 102(2):152-5. PubMed ID: 18456267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
    Huang SM; Liao WT; Lin CF; Sun HS; Chow NH
    World J Surg; 2016 Mar; 40(3):505-9. PubMed ID: 26546192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
    Araruna LVM; de Oliveira DC; Pereira MC; Moura Neto A; Tambascia MA; Zantut-Wittmann DE
    Front Endocrinol (Lausanne); 2021; 12():780397. PubMed ID: 35069439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease].
    Amodio F; Di Martino S; Esposito S; Iorio S; Hierholzer J; Rea G; Bizzarro A; Vallone G
    Radiol Med; 2001 Oct; 102(4):233-7. PubMed ID: 11740450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves' Disease from Thyroiditis.
    Sarangi PK; Parida S; Mangaraj S; Mohanty BK; Mohanty J; Swain BM
    Indian J Radiol Imaging; 2021 Apr; 31(2):311-317. PubMed ID: 34556913
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
    Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome.
    Castagnone D; Rivolta R; Rescalli S; Baldini MI; Tozzi R; Cantalamessa L
    AJR Am J Roentgenol; 1996 Jan; 166(1):203-7. PubMed ID: 8571877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease].
    Li J; Zhang J; Bai Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):170-4. PubMed ID: 7805159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.